EIPFX yields 12.89% · MRK yields 3.25%● Live data
📍 EIPFX pulled ahead of the other in Year 1
Combined, EIPFX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EIPFX + MRK for your $10,000?
The investment seeks to provide a high level of total shareholder return that is balanced between current income and growth; it seeks low volatility as a secondary objective. Under normal market conditions, the fund pursues its objectives by investing primarily in a diversified portfolio of equity securities of issuers in the energy industry ("Energy Companies") that seek to pay out as dividends or distributions a portion of income or distributable cash flow in excess of the average for listed equities as a whole. It concentrates its investments in the Energy Industry and may invest without limit in Energy Companies of any market capitalization.
Full EIPFX Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.